Literature DB >> 16614995

Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection.

B Schroeder1, S Duncker, S Barth, R Bauerfeind, A D Gruber, S Deppenmeier, G Breves.   

Abstract

Pretreatment with the probiotic Escherichia colistrain Nissle 1917 (EcN) was assessed in a pig model of intestinal infection to prevent acute secretory diarrhea. In the model 10(10) colony forming units of the porcine enterotoxigenic Escherichia coli Abbotstown (EcA) was given via orogastric tube to weaned piglets at day 21 postpartum (-EcN/+EcA group, n = 7). Forty-eight hours after challenge electrophysiological parameters of isolated intact jejunal epithelia were characterized in Ussing chambers. In agreement with clinical signs of diarrhea, tissues of challenged animals showed an overshoot of secretory response after stimulation of the cAMP-mediated second messenger pathway by forskolin, indicating higher excitability of chloride secretory systems under infected conditions. The data were compared with respective measurements from animals that got a daily dose of 10(10) cfu of the probiotic EcN over 10 days before EcA challenge (+EcN/+EcA group; n = 4), from a group that received only EcN (+EcN/-EcA; n = 4), or from a group that remained totally untreated (-EcN/-EcA; n = 6). EcN pretreatment completely abolished clinical signs of secretory diarrhea in +EcN/+EcA animals. Furthermore, jejunum epithelia of these animals did not exhibit an overshoot of secretory response upon stimulation with forskolin. Our studies demonstrate for the first time the efficacy of prophylactic EcN in pig small intestine for preventing an effect of toxigenic EcA. This infection model with freshly weaned piglets may be predestinated to further characterize EcN effects on the cellular level, i.e., involved second messenger pathways, or it may also be useful to examine the efficacy of other substrates or microbe strains against secretory stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614995     DOI: 10.1007/s10620-006-3198-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

1.  Tight junctional structure and permeability of porcine jejunum after enterotoxic Escherichia coli infection.

Authors:  H J Egberts; E C de Groot; J E van Dijk; L Vellenga; J M Mouwen
Journal:  Res Vet Sci       Date:  1993-07       Impact factor: 2.534

2.  Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.

Authors:  I Castagliuolo; M Riegler; A Pasha; S Nikulasson; B Lu; C Gerard; N P Gerard; C Pothoulakis
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

3.  [Distribution of Brachyspira hyodysenteriae and Lawsonia intracellularis in healthy and diarrhoeic pigs].

Authors:  Werner Herbst; Hermann Willems; Georg Baljer
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2004 Nov-Dec       Impact factor: 0.328

4.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

5.  Enhanced detection of intracellular organism of swine proliferative enteritis, ileal symbiont intracellularis, in feces by polymerase chain reaction.

Authors:  G F Jones; G E Ward; M P Murtaugh; G Lin; C J Gebhart
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Coliform numbers in the stomach and small intestine of healthy pigs following weaning at three weeks of age.

Authors:  D J Hampson; M Hinton; D E Kidder
Journal:  J Comp Pathol       Date:  1985-07       Impact factor: 1.311

7.  Dietary flavonol quercetin induces chloride secretion in rat colon.

Authors:  R Cermak; U Föllmer; S Wolffram
Journal:  Am J Physiol       Date:  1998-11

8.  The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

Authors:  Artur Altenhoefer; Sibylle Oswald; Ulrich Sonnenborn; Corinne Enders; Juergen Schulze; Joerg Hacker; Tobias A Oelschlaeger
Journal:  FEMS Immunol Med Microbiol       Date:  2004-04-09

9.  Neurohormonal regulation of ion transport in the porcine distal jejunum. Actions of somatostatin-14 and its natural and synthetic homologs.

Authors:  D R Brown; M F Overend; B G Treder
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

Review 10.  Probiotics and the management of inflammatory bowel disease.

Authors:  Richard N Fedorak; Karen L Madsen
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325

View more
  27 in total

1.  Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.

Authors:  David Smajs; Jan Bureš; Jan Smarda; Eva Chaloupková; Jaroslav Květina; Miroslav Förstl; Darina Kohoutová; Martin Kuneš; Stanislav Rejchrt; Jiřina Lesná; Marcela Kopáčová
Journal:  Curr Microbiol       Date:  2011-11-25       Impact factor: 2.188

2.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

3.  Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

Authors:  A Splichalova; I Trebichavsky; V Rada; E Vlkova; U Sonnenborn; I Splichal
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

4.  Effects of Ex Vivo Infection with ETEC on Jejunal Barrier Properties and Cytokine Expression in Probiotic-Supplemented Pigs.

Authors:  Ulrike Lodemann; Salah Amasheh; Judith Radloff; Martina Kern; Astrid Bethe; Lothar H Wieler; Robert Pieper; Jürgen Zentek; Jörg R Aschenbach
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

5.  Response of nursery pigs to a synbiotic preparation of starch and an anti-Escherichia coli K88 probiotic.

Authors:  D O Krause; S K Bhandari; J D House; C M Nyachoti
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

6.  In vitro evaluation of the effect of a high plant protein diet and nucleotide supplementation on intestinal integrity in meagre (Argyrosomus regius).

Authors:  M A Sáenz de Rodrigáñez; J Fuentes; F J Moyano; L Ribeiro
Journal:  Fish Physiol Biochem       Date:  2013-03-24       Impact factor: 2.794

7.  Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Authors:  Sylvia Kleta; Marcel Nordhoff; Karsten Tedin; Lothar H Wieler; Rafal Kolenda; Sibylle Oswald; Tobias A Oelschlaeger; Wilfried Bleiss; Peter Schierack
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

8.  Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats.

Authors:  Ying-Jie Sun; Hui-Juan Cao; Dan-Dan Song; Yu-Gang Diao; Jin Zhou; Tie-Zheng Zhang
Journal:  Dig Dis Sci       Date:  2013-01-19       Impact factor: 3.199

9.  Use of Attenuated but Metabolically Competent Salmonella as a Probiotic To Prevent or Treat Salmonella Infection.

Authors:  Anice Sabag-Daigle; Henry M Blunk; Juan F Gonzalez; Brandi L Steidley; Prosper N Boyaka; Brian M M Ahmer
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

10.  Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract.

Authors:  Andreas Kupz; André Fischer; Dietrich H Nies; Gregor Grass; Ulf B Göbel; Stefan Bereswill; Markus M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.